CrossBridge Bio’s pipeline includes a potential best-in-class TROP2-targeting TOP1i/ATRi dual-payload ADC anticipated to enter the clinic in 2026Acquisition provides an innovative synergistic dual ...
Researchers identified GSK3α as a key checkpoint controlling stem cell identity across multiple cell types. Inhibiting it ...
GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM aimed to help healthcare and life sciences organizations accelerate the adoption of ...
Dutch biotech Laigo Bio, which is pioneering novel and highly differentiated therapies using its proprietary SureTACs ...
Innovative biotechnology company CrossBridge Bio to be acquired by US pharmaceutical major Eli Lilly in up to USD 300 million ...
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
The damage from smoking has long been traced through the lungs, heart, and blood vessels. But another pathway may be helping ...
Advancing a broad portfolio designed to deliver multiple paradigm-shifting therapies for devastating and underserved immune-mediated diseases – ...
ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc. (Nasdaq:AIDX), Society Pass Inc. (Nasdaq:SOPA ...
The mill's new collection is built on three pillars: material transformation, process optimization and product longevity.
The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results